✦ LIBER ✦

9021 Preliminary results of MAGE-A3 expression and baseline demographic data from MAGRIT, a large phase III trial of MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic) in adjuvant NSCLC

✍ Scribed by Zielinski, M.; Laskowski, U.; Bieselt, R.; Reck, M.; Strausz, J.; Perdeus, J.; Park, K.; Atanackovic, D.; Debois, M.; Debruyne, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP55 A MAGE-A3 specific quantitative RT-

✍ T. Coche; J. Louahed; O. Gruselle; H. Wu; H. Hoffmann; E. Esteban-Gonzales; P. T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

MAGE-A3 Antigen-Specific Cancer Immunoth

✍ Eisen, T.; Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabreh, J.; Jassem, J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

102PD MAGE-A3 ANTIGEN-SPECIFIC CANCER IM

✍ Passlick, B.; Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabreh, J.; Esteba 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB